Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
about
Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infectionSingle amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionCrystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assemblyCharacterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayEfficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domainThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assayIn vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.Identification of retroviral late domains as determinants of particle size.Baculovirus display of single chain antibody (scFv) using a novel signal peptideGenetic determinants of Rous sarcoma virus particle size.Particle size determinants in the human immunodeficiency virus type 1 Gag proteinDetection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.Structural analysis of membrane-bound retrovirus capsid proteins.Tripeptide interference with human immunodeficiency virus type 1 morphogenesis.p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing proteaseEffects of Gag mutation and processing on retroviral dimeric RNA maturation.Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.A long terminal repeat-containing retrotransposon of Schizosaccharomyces pombe expresses a Gag-like protein that assembles into virus-like particles which mediate reverse transcription.Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivitySequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17.Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cellsComparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly.Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.Functional domains of the capsid protein of human immunodeficiency virus type 1A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodiesVif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes.Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag.The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivityMyristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells.HIV Gag-leucine zipper chimeras form ABCE1-containing intermediates and RNase-resistant immature capsids similar to those formed by wild-type HIV-1 Gag.
P2860
Q24673913-006AF2FA-D211-4D83-9DAB-D1F0CA522CB7Q27485930-9B160FA0-34F9-41E0-A807-C9F4F0161095Q27732646-753B719D-16AD-4811-B005-D5D5F6355908Q28477791-2C60F16D-E830-45AB-A671-FEAFFA72B1E6Q28478202-C1A2BF7C-5B33-429C-9D8F-118A393CF711Q30440445-A19F2578-DB3C-499C-9625-75417722FC15Q30447057-2A464135-0B9A-4F58-B335-F45E27515559Q33653475-FB2331A2-2864-4D13-93D4-6FB18F632509Q33653548-38501B7C-4EFF-4FB1-9CAE-457BBAFD6314Q33751786-64BE8E8D-CD77-4B6A-9B64-1C86E61A6516Q33782075-D6AF8C56-FF8F-4F32-BE5D-EBB7662003CCQ33783955-6B184BE4-1EB1-4704-A920-90E28D1D7021Q33784101-A3179DD2-365F-419B-A693-0816D5AA32DEQ33784754-4E8C88D9-7C64-4BEE-8769-BA9255564DBFQ33820522-8B4C3D1B-144C-45B0-ACFD-1D5B7E14F927Q33886226-5AFF3179-A3D1-4CDF-80EF-D79C9EAE2B31Q34141649-F821511D-A0E9-4A41-A53D-C825A0061FD8Q34288376-22ED3F28-15A6-4F6D-9FB3-606A70F2760BQ34302140-2BDE8A5C-9E52-4376-8917-80CFAAED0709Q34304675-1D935228-0685-427F-B24A-3ACD99C097F6Q34975957-D56D735B-68D4-455E-8F4F-ADF2CBB5250DQ35829873-658D13E9-0A86-4E4E-BE3B-48BA8335D6F7Q35830898-334D7ACA-876C-4306-B916-7E9CDD3A99C2Q35834904-B9C86DCD-BFE6-4D3A-B9ED-F5A913C2F306Q35837753-8EF605E5-8CB2-4BF6-9C38-A91E0BFD47F1Q35841323-BB2FA794-00E5-4A68-A659-5E20DCD93565Q35842199-EA80E717-22F9-4EEF-BA06-B89FB3E9D755Q35886606-C21A1FFA-B8A1-4894-8F98-46D8AF67A849Q35888172-D73D0B1F-6247-4290-A11A-581FF270C6E4Q36279578-AA8CF1F8-8C9E-4BA2-8E18-C6D19B969D15Q36624411-B14366F5-C9B2-477F-8AE8-F7D35B6ABA6AQ36638060-28908395-98D2-4F78-8040-86D07A62CB2FQ36889041-0A649823-7249-4841-9F41-C75E8EA21644Q39549710-8F9DF2B5-C20D-49B4-AF17-1103D6DBCCC9Q39685850-FF7E96B3-2449-4AC3-9910-50E2B49D7C34Q39870242-38E23F99-7983-4AAA-9BED-1621AEDF326FQ40078275-8ABDEBB6-D80D-4D58-9C37-6C0A6DF27246Q42780222-BF04B090-F60D-4478-91D6-DC7A0B6B1AA8
P2860
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Phenotypic characterization of ...... nt baculovirus-infected cells.
@ast
Phenotypic characterization of ...... nt baculovirus-infected cells.
@en
type
label
Phenotypic characterization of ...... nt baculovirus-infected cells.
@ast
Phenotypic characterization of ...... nt baculovirus-infected cells.
@en
prefLabel
Phenotypic characterization of ...... nt baculovirus-infected cells.
@ast
Phenotypic characterization of ...... nt baculovirus-infected cells.
@en
P2093
P2860
P1433
P1476
Phenotypic characterization of ...... nt baculovirus-infected cells.
@en
P2093
P2860
P304
P407
P577
1994-01-01T00:00:00Z